HCV E2 Antikörper

Produktnummer ABIN2859512

Produktdetails anti-HCV E2 Antikörper

Target: HCV E2 (Hepatitis C Virus Envelope Protein E2 (HCV E2))

Reaktivität: Hepatitis C Virus (HCV)

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser HCV E2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA), Immunohistochemistry (Frozen Sections) (IHC (fro))

Aufreinigung: Protein A Chromatography.

Immunogen: Recombinant HCV E2, genotype 1a.

Klon: BDI167

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Suitable for use in ELISA, IFA and Western blot. Recommended Starting Dilutions: 1/20-1/200 for ELISA.1/10-1/50 for IFA and Western blot. Has been reported to work in immunohistochemistry on frozen sections.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1.0 mg/mL (OD280nm, E0.1% = 1.3)

Buffer: 0.01 M PBS, pH 7.2 with 0.09 % Sodium Azide as preservative.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Upon receipt, store (in aliquots) at -20 °C.

Details zu HCV E2

Target: HCV E2 (Hepatitis C Virus Envelope Protein E2 (HCV E2))

Andere Bezeichnung: HCV Envelope Glycoprotein E2 (HCV E2 Produkte)

Substanzklasse: Viral Protein

Hintergrund: Hepatitis C Virus is a positive, single-stranded RNA virus in the Flaviviridae family. The genome is approximately 10,000 nucleotides and encodes a single polyprotein of about 3,000 amino acids. The polyprotein is processed by host cell and viral proteases into three major structural proteins and several non-structural protein necessary for viral replication. Several different genotypes of HCV with slightly different genomic sequences have since been identified that correlate with differences in response to treatment with interferon alpha.Synonyms: Hepatitis C Virus NS1, gp68, gp70